Illinois General Assembly - Bill Status for HB 1

Replaces everything after the enacting clause. Amends the Open Meetings Act. Exempts from the requirements of the Act those meetings or portions of meetings of the Advisory Committee created under the Illinois Controlled Substances Act during which specific controlled substance prescriber, dispenser, or patient information is discussed. Amends the State Employees Group Insurance Act of 1971 in relation to required health benefits. Amends the Alcoholism and Other Drug Abuse and Dependency Act. Requires the Medical Director of the Department of Public Health to write a standing order for the dispensing by pharmacists in any willing pharmacy of an opioid antidote to individuals who may or may not be personally at risk for opioid overdose. Requires every State and local government agency that employs a law enforcement officer or fireman to possess opioid antidotes and to establish a policy to control the acquisition, storage, transportation, and administration of such opioid antidotes and to provide training in the administration of opioid antidotes. Establishes a similar requirement for publicly or privately owned providers of pre-hospital and inter-hospital emergency medical services that employ an emergency medical technician or an emergency medical responder. Makes other changes. Amends the Department of Human Services Act. Requires the Department of Human Services to establish, by rule, a medication take-back program to allow for the collection and disposal of unused medications. Amends the Department of State Police Law in relation to a training program for State police officers in the administration of opioid antidotes. Amends the State Finance Act. Creates the Parity Education Fund. Amends the Illinois Police Training Act in relation to a training program for police officers in the administration of opioid antidotes. Amends the Illinois Fire Protection Training Act in relation to a training program for fire fighters in the administration of opioid antidotes. Amends the Counties Code. Requires the coroner or medical examiner to report to the Department of Public Health cases where a drug overdose is determined to be the cause or a contributing factor in a person's death. Amends the Illinois Municipal Code in relation to required health benefits covered by a municipality that is a self-insurer. Amends the School Code. Permits a school nurse or trained personnel to administer an opioid antidote to any person having an opioid overdose; requires the State Board of Education and the Department of Human Services to establish, by January 1, 2017, a heroin and opioid prevention pilot program; and makes other changes. Amends the Emergency Medical Services (EMS) Systems Act in relation to education and training requirements for EMT and EMR personnel in the administration of opioid antidotes. Amends the Hospital Licensing Act. Requires the Department of Public Health to submit semiannual reports to the General Assembly on drug overdoses and the use of opioid antidotes. Amends the Illinois Insurance Code in relation to coverage for opioid antidotes and other matters. Amends the Health Carrier External Review Act in relation to Request for External Review forms and other matters. Amends the Medical Practice Act of 1987 in relation to continuing education hours for licensed physicians on the abuse of controlled substances. Amends the Medical Assistance Article of the Illinois Public Aid Code in relation to coverage for injectable naltrexone; required health benefits; and other matters. Amends the Criminal Code of 2012 in relation to the purchase of opioid antidotes with the moneys and sale proceeds of forfeited property and other matters. Amends the Cannabis Control Act in relation to drug court programs for persons sentenced to probation. Amends the Illinois Controlled Substances Act in relation to electronic health records; pain clinic registration and licensing; prescriptions for a Schedule II controlled substance; the prescription monitoring program; prescriber oversight; and other matters. Amends the Methamphetamine Control and Community Protection Act in relation to drug court programs for persons sentenced to probation. Amends the Unified Code of Corrections in relation to referring a person suffering from a serious substance abuse problem to a drug court program before permitting the person to participate in the Offender Initiative Program. Amends the Drug Court Treatment Act in relation to education seminars for drug court prosecutors and public defenders. Amends the Veterans and Servicemembers Court Treatment Act. Exempts pharmacists from civil liability for dispensing an opioid antidote to individuals who may or may not be at risk for an opioid overdose.

Replaces everything after the enacting clause. Reinserts the provisions of House Amendment No. 1, but with the following changes: Further amends the Open Meetings Act by exempting meetings or portions of meetings of the peer review subcommittee created under the Illinois Controlled Substances Act. Further amends the Alcoholism and Other Drug Abuse and Dependency Act as follows: Provides that the Director of the Division of Alcoholism and Substance Abuse shall (rather than may) publish annually a report on drug overdose trends statewide that reviews State death rates from available data to ascertain changes in the causes or rates of fatal and nonfatal drug overdose (rather than from available data to ascertain changes in the causes or rates of fatal and nonfatal drug overdose for the preceding period of not less than 5 years). Requires the report to include an analysis of drug overdose information reported to the Department of Public Health pursuant to the Counties Code and the Hospital Licensing Act. Provides that the report may include a description of efforts undertaken to educate the public about unused medication and about how to properly dispose of unused medication, including the number of registered collection receptacles in this State, mail-back programs, and drug take-back events. Defines "opioid antagonist" (rather than "opioid antidote"). Changes all instances of "opioid antidote" to "opioid antagonist" and makes corresponding changes in various laws. Exempts health care professionals who prescribe or dispense an opioid antagonist in certain situations from criminal liability, except for willful and wanton misconduct. Adds pharmacists to the list of persons the Director of the Division of Alcoholism and Substance Abuse shall consult with when developing and disseminating to health care professionals information on drug overdose prevention and recognition and other matters. Provides that every publicly or privately owned ambulance, special emergency medical services vehicle, non-transport vehicle, or ambulance assist vehicle, as described in the Emergency Medical Services (EMS) Systems Act, which responds to requests for emergency services or transports patients between hospitals in emergency situations must possess opioid antagonists (rather than requiring every publicly or privately owned provider of pre-hospital and inter-hospital emergency medical services to possess opioid antagonists and to establish a policy to control the acquisition, storage, transportation, and administrations of such opioid antagonists and to provide training in the administration of opioid antagonists). Makes changes to a provision concerning immunity from prosecution. Amends the Department of Human Services Act. Provides that the Illinois Environmental Protection Agency shall establish, by rule, a medication take-back program to allow for the collection and disposal of unused controlled substances (rather than unused medications); and makes other changes. Further amends the Illinois Fire Protection Training Act. Provides that the Office of the State Fire Marshal shall distribute (rather than conduct or approve) an in-service training program for fire fighters in the administration of opioid antagonists that is developed by the Department of Human Services. Amends the Illinois Criminal Justice Information Act. Provides that moneys in the Prescription Pill and Drug Disposal Fund shall be used for grants by the Illinois Criminal Justice Information Authority to municipalities or organizations that establish containers designated for the collection and disposal of unused controlled substances and that conduct the collection of unused controlled substances through mail-back programs. Further amends the School Code. Changes the definition of "asthma medication" to add a physician assistant who has been delegated prescriptive authority (rather than the authority to prescribe asthma medications) by his or her supervising physician to the list of asthma medication prescribers. Makes a change to the definitions of "standing protocol" and "undesignated epinephrine auto-injector". Requires the State Board of Education to submit a report to the General Assembly and the Department of Public Health (rather than the General Assembly) identifying the frequency and circumstances of opioid antagonist administration during the preceding academic year. Makes changes to the Hospital Licensing Act requiring health care professionals to report drug overdose cases to the Department of Public Health within a specified time period. Removes changes made to the Medical Practice Act of 1987 concerning mandatory continuing education hours on the abuse of controlled substances for licensed physicians. Further amends the Emergency Medical Services (EMS) Systems Act by requiring the EMS Medical Directors Committee to address regional standing medical orders for the administration of opioid antagonists and by granting the Department of Public Health the authority to prescribe education and training requirements in the administration and use of opioid antagonists for all levels of EMS personnel based on the National EMS Educational Standards and any modifications to those curricula specified by the Department through rules adopted pursuant to the Act (rather than the Department shall have the authority to prescribe education and training requirements for EMT and EMR personnel in the administration of opioid antagonists). Further amends the Illinois Insurance Code. Provides that coverage for opioid antagonists must include refills for expired or utilized opioid antagonists. Makes changes to the definition of "opioid antagonist". Provides that an individual or group health benefit plan amended, delivered, issued, or renewed on or after the effective date of the amendatory Act shall offer (rather than provide) coverage for medically necessary acute treatment services and medically necessary clinical stabilization services (rather than coverage for medically necessary acute treatment services and medically necessary clinical stabilization services for up to a total of 21 days before initiating utilization review procedure and shall not require preauthorization prior to obtaining acute treatment services or clinical stabilization services). Removes amendatory changes concerning external independent review decisions and appeals; uncertainty or disagreement with the enforcement of the provisions of a parity law; annual reports on the percentages of premiums spent on reimbursement for clinical service; annual reports on the percentage of capitated payments for mental health and substance use disorder services; and other matters. Adds a provision concerning the availability of plan information. Makes changes to the definition of "treatment limitation". Amends the Pharmacy Practice Act. Provides that notwithstanding any general or special law to the contrary, a licensed pharmacist may dispense an opioid antagonist in accordance with written, standardized procedures or protocols developed by the Department of Financial and Professional Regulation with the Department of Public Health and the Department of Human Services if the procedures or protocols are filed at the pharmacy before implementation and are available to the Department of Financial and Professional Regulation upon request. Requires a pharmacist to complete a training program approved by the Department of Human Services before dispensing an opioid antagonist. Further amends the Illinois Public Aid Code. Provides that notwithstanding any other provision of the Code to the contrary, on or after July 1, 2015, injectable naltrexone prescribed for the treatment of alcohol dependence or the prevention of a relapse to opioid dependence (rather than prescribed by a physician for the treatment of alcohol dependence or the prevention of a relapse to opioid dependence) shall be covered under the medical assistance program. Provides that on or after July 1, 2015, methadone prescribed for the treatment of opioid dependence (rather than prescribed by a physician for the treatment of opioid dependence) shall be covered under the medical assistance program. Provides that on or after July 1, 2015, opioid antagonists prescribed for the treatment of an opioid overdose (rather than opioid antidotes prescribed by a physician for the treatment of an opioid overdose) shall be covered under the medical assistance program. Provides that all moneys and sale proceeds of property forfeited and seized under specified provisions of the Code may be used to provide to the Department of Human Services funds to develop and implement the educational programs required pursuant to certain provisions under the Alcoholism and Other Drug Abuse and Dependency Act and the School Code. Further amends the Criminal Code of 2012 by renumbering certain provisions, removing amendatory changes concerning criminal or civil forfeitures, and removing an amendatory change extending the repeal date of the Illinois Street Gang and Racketeer Influenced and Corrupt Organizations Law Article to June 11, 2022. Further amends the Cannabis Control Act. Provides that before a person is (rather than may be) sentenced to probation, the court may (rather than shall) refer the person to drug court. Provides that if the drug court team finds that the person suffers from a substance abuse problem (rather than a severe substance abuse problem) that makes him or her substantially unlikely to successfully complete a sentence of probation, then the drug court shall set forth its findings in the form of a written order, and the person shall not be sentenced to probation, but may be considered for the drug court program. Makes similar changes in the Illinois Controlled Substances Act, the Methamphetamine Control and Community Protection Act, and the Unified Code of Corrections. Removes amendatory change imposing a $25 monthly fee on the person sentenced to probation. Further amends the Illinois Controlled Substances Act as follows: (i) makes a change to the definition of "prescription"; (ii) removes a provision concerning pain clinic registration and licensing; (iii) adds a provision requiring a physician to document in the medical record of a patient the medical necessity for the amount and duration of the 3 sequential 30-day prescriptions for Schedule II narcotics; (iv) removes a provision permitting pharmacies to fill a 10-day supply of a Schedule II controlled substance at one time subject to prescriber authorization and removes a provision requiring a prescriber to conduct an assessment of the patient regarding possible addiction tendencies and predisposition for substance abuse before issuing the first prescription in a single course of treatment for a Schedule II controlled substance; (v) removes language concerning certain actions a prescriber must take upon receipt of an unsolicited report issued by the Prescription Monitoring Program; (vi) adds a provision prohibiting the use of patient feedback as the basis of any adverse action, evaluation, or any other type of negative credentialing, contracting, licensure, or employment action taken against a prescriber or dispenser; (vii) restores language providing that nothing shall create a requirement that any prescriber, dispenser, or pharmacist request any patient medication disclosure, report any patient activity, or prescribe or refuse to prescribe or dispense any medications; (viii) removes a provision requiring the Department of Financial and Professional Regulation to adopt rules on or before January 1, 2016 regarding the oversight of prescriber practices as reported to the Prescription Monitoring Program; (ix) changes provisions concerning the prescription monitoring program and the central repository for the collection of certain information transmitted under the Act; (x) adds provisions requiring the Prescription Monitoring Program: to automatically create a log-in to the inquiry system when a prescriber or dispenser obtains or renews his or her controlled substance license; to maintain an Internet website in conjunction with its prescriber and dispenser inquiry system; and to regularly send electronic updates to the registered users of the Program; (xi) requires the Department of Financial and Professional Regulation to adopt rules concerning certain matters; (xii) creates the Prescription Monitoring Program Advisory Committee to assist the Department of Human Services in implementing the Prescription Monitoring Program (rather than the Secretary of the Department of Human Services must appoint an advisory committee to assist the Department of Financial and Professional Regulation in implementing the controlled substance prescription monitoring program); (xiii) in a provision requiring the Clinical Director of the Prescription Monitoring Program to select 5 members to serve on a peer review subcommittee, requires the peer review subcommittee to prepare an annual report starting on July 1, 2017; (xiv) makes it a Class A misdemeanor to knowingly withhold information requested from a practitioner, with the intent to obtain a controlled substance that has not been prescribed, by misrepresentation, fraud, forgery, deception, subterfuge, or concealment of a material fact; and (xv) makes other changes. Further amends the Unified Code of Corrections by increasing the fee amount for certain drug and methamphetamine related offenses. Further amends the Good Samaritan Act in a provision exempting pharmacists from civil liability for the dispensing of an opioid antagonist to individuals who may or may not be at risk for an opioid overdose. Adds an immediate effective date.

Date	Chamber	Action
9/11/2015	House	Public Act . . . . . . . . . 99-0480

Date	Chamber	Action
1/14/2015	House	Filed with the Clerk by Rep. Lou Lang
1/14/2015	House	First Reading
1/14/2015	House	Referred to Rules Committee
2/3/2015	House	Assigned to Executive Committee
2/13/2015	House	Added Chief Co-Sponsor Rep. John D. Anthony
2/24/2015	House	Re-assigned to Substance Abuse Special
2/26/2015	House	Added Chief Co-Sponsor Rep. Litesa E. Wallace
2/27/2015	House	Added Chief Co-Sponsor Rep. Sam Yingling
3/2/2015	House	Added Chief Co-Sponsor Rep. John M. Cabello
3/2/2015	House	House Committee Amendment No. 1 Filed with Clerk by Rep. Lou Lang
3/2/2015	House	House Committee Amendment No. 1 Referred to Rules Committee
3/2/2015	House	Remove Chief Co-Sponsor Rep. John M. Cabello
3/3/2015	House	House Committee Amendment No. 1 Rules Refers to Substance Abuse Special
3/3/2015	House	Added Co-Sponsor Rep. Gregory Harris
3/3/2015	House	Added Co-Sponsor Rep. Jaime M. Andrade, Jr.
3/5/2015	House	Added Co-Sponsor Rep. Kathleen Willis
3/5/2015	House	Added Co-Sponsor Rep. Frances Ann Hurley
3/5/2015	House	Added Co-Sponsor Rep. Brian W. Stewart
3/5/2015	House	Added Co-Sponsor Rep. Lawrence Walsh, Jr.
3/5/2015	House	Added Co-Sponsor Rep. Emanuel Chris Welch
3/11/2015	House	Added Co-Sponsor Rep. Grant Wehrli
3/25/2015	House	House Committee Amendment No. 1 Adopted in Substance Abuse Special; by Voice Vote
3/25/2015	House	Do Pass as Amended / Short Debate Substance Abuse Special; 008-000-000
3/25/2015	House	Placed on Calendar 2nd Reading - Short Debate
4/22/2015	House	Second Reading - Short Debate
4/22/2015	House	Held on Calendar Order of Second Reading - Short Debate
4/24/2015	House	Rule 19(a) / Re-referred to Rules Committee
5/12/2015	House	Approved for Consideration Rules Committee; 003-000-000
5/12/2015	House	Final Action Deadline Extended-9(b) May 15, 2015
5/12/2015	House	Placed on Calendar 2nd Reading - Short Debate
5/14/2015	House	House Floor Amendment No. 2 Filed with Clerk by Rep. Lou Lang
5/14/2015	House	House Floor Amendment No. 2 Referred to Rules Committee
5/15/2015	House	Final Action Deadline Extended-9(b) May 22, 2015
5/18/2015	House	House Floor Amendment No. 2 Rules Refers to Substance Abuse Special
5/20/2015	House	House Floor Amendment No. 2 Recommends Be Adopted Substance Abuse Special; 008-000-000
5/20/2015	House	House Floor Amendment No. 3 Filed with Clerk by Rep. Lou Lang
5/20/2015	House	House Floor Amendment No. 3 Referred to Rules Committee
5/21/2015	House	House Floor Amendment No. 3 Recommends Be Adopted Rules Committee; 003-001-000
5/21/2015	House	Second Reading - Short Debate
5/21/2015	House	House Floor Amendment No. 2 Adopted
5/21/2015	House	House Floor Amendment No. 3 Adopted
5/21/2015	House	Placed on Calendar Order of 3rd Reading - Short Debate
5/21/2015	House	Added Co-Sponsor Rep. Will Guzzardi
5/22/2015	House	Added Co-Sponsor Rep. Laura Fine
5/22/2015	House	Added Co-Sponsor Rep. Robyn Gabel
5/22/2015	House	Added Co-Sponsor Rep. Patricia R. Bellock
5/22/2015	House	Final Action Deadline Extended-9(b) May 31, 2015
5/26/2015	House	House Floor Amendment No. 2 Fiscal Note Filed as Amended
5/26/2015	House	House Floor Amendment No. 3 Fiscal Note Filed as Amended
5/27/2015	House	Added Co-Sponsor Rep. David R. Leitch
5/27/2015	House	Added Co-Sponsor Rep. Carol Ammons
5/27/2015	House	Added Co-Sponsor Rep. Emily McAsey
5/27/2015	House	Third Reading - Short Debate - Passed 114-000-000
5/27/2015	House	Added Co-Sponsor Rep. Cynthia Soto
5/27/2015	House	Added Co-Sponsor Rep. Ann M. Williams
5/27/2015	House	Added Co-Sponsor Rep. La Shawn K. Ford
5/27/2015	House	Added Co-Sponsor Rep. Elizabeth Hernandez
5/27/2015	House	Added Co-Sponsor Rep. Robert Martwick
5/27/2015	House	Added Co-Sponsor Rep. Silvana Tabares
5/27/2015	House	Added Co-Sponsor Rep. John C. D'Amico
5/27/2015	House	Added Co-Sponsor Rep. Luis Arroyo
5/27/2015	House	Added Co-Sponsor Rep. Eddie Lee Jackson, Sr.
5/27/2015	House	Added Co-Sponsor Rep. Arthur Turner
5/27/2015	House	Added Co-Sponsor Rep. Carol Sente
5/27/2015	House	Added Co-Sponsor Rep. Jack D. Franks
5/27/2015	House	Added Co-Sponsor Rep. Sara Feigenholtz
5/27/2015	House	Added Co-Sponsor Rep. Patrick J. Verschoore
5/27/2015	House	Added Co-Sponsor Rep. Christian L. Mitchell
5/27/2015	House	Added Co-Sponsor Rep. David Harris
5/27/2015	Senate	Arrive in Senate
5/27/2015	Senate	Placed on Calendar Order of First Reading
5/27/2015	Senate	Chief Senate Sponsor Sen. Dan Kotowski
5/27/2015	Senate	Added as Alternate Chief Co-Sponsor Sen. Pat McGuire
5/27/2015	Senate	First Reading
5/27/2015	Senate	Referred to Assignments
5/27/2015	Senate	Added as Alternate Chief Co-Sponsor Sen. Thomas Cullerton
5/28/2015	Senate	Added as Alternate Chief Co-Sponsor Sen. Jennifer Bertino-Tarrant
5/28/2015	Senate	Motion Filed Sen. Dan Kotowski; to Waive Posting Notice
5/28/2015	Senate	Motion Prevailed 038-016-000
5/28/2015	Senate	Waive Posting Notice
5/28/2015	Senate	Assigned to Executive
5/28/2015	Senate	Added as Alternate Chief Co-Sponsor Sen. Michael Noland
5/28/2015	Senate	Added as Alternate Co-Sponsor Sen. Andy Manar
5/28/2015	Senate	Do Pass Executive; 010-001-003
5/28/2015	Senate	Placed on Calendar Order of 2nd Reading May 29, 2015
5/29/2015	Senate	Added as Alternate Co-Sponsor Sen. Donne E. Trotter
5/29/2015	Senate	Added as Alternate Co-Sponsor Sen. Iris Y. Martinez
5/29/2015	Senate	Second Reading
5/29/2015	Senate	Placed on Calendar Order of 3rd Reading May 30, 2015
5/29/2015	Senate	Rule 2-10 Third Reading Deadline Established As May 31, 2015
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. David Koehler
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Patricia Van Pelt
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. William Delgado
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Michael E. Hastings
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Jacqueline Y. Collins
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Melinda Bush
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Julie A. Morrison
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Linda Holmes
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Steve Stadelman
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Karen McConnaughay
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Pamela J. Althoff
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Michael Connelly
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Sue Rezin
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. William R. Haine
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Mattie Hunter
5/30/2015	Senate	Added as Alternate Co-Sponsor Sen. Napoleon Harris, III
5/30/2015	Senate	Third Reading - Passed; 046-004-006
5/30/2015	House	Passed Both Houses
6/26/2015	House	Sent to the Governor
8/24/2015	House	Governor Amendatory Veto
8/25/2015	House	Placed on Calendar Amendatory Veto August 25, 2015
8/25/2015	House	Motion Filed Override Amendatory Veto Rep. Lou Lang
9/2/2015	House	Added Co-Sponsor Rep. Pamela Reaves-Harris
9/2/2015	House	3/5 Vote Required
9/2/2015	House	Override Amendatory Veto - House Passed 105-005-000
9/9/2015	Senate	Placed on Calendar Amendatory Veto
9/9/2015	Senate	Motion Filed Override Amendatory Veto Sen. Dan Kotowski
9/9/2015	Senate	3/5 Vote Required
9/9/2015	Senate	Added as Alternate Co-Sponsor Sen. Dan Duffy
9/9/2015	Senate	Override Amendatory Veto - Senate Passed 044-011-000
9/9/2015	House	Amendatory Veto Overridden Both Houses
9/11/2015	House	Effective Date September 9, 2015
9/11/2015	House	Public Act . . . . . . . . . 99-0480

	Fiscal Note, House Floor Amendment No. 2 (Dept. of Human Services)
	HB 1 (H-AM 2) has an estimated cost of $15.4 million.

	Fiscal Note, House Floor Amendment No. 3 (Dept. of Human Services)
	HB 1 (H-AM 3) has an estimated cost of $15.4 million.

	Deletes reference to:
	New Act

	Adds reference to:
	5 ILCS 120/2	from Ch. 102, par. 42